Distinct genetic and immunological features in patients with onset of IDDM before and after age 40

Diabetes Care

Volumn 20, Issue 4, 1997, Pages 524-529

  Lohmann, Tobias ^a   Seissler, Jochen ^a   Verlohren, Hans Joachim ^b   Schröder, Sabine ^a   Rötger, Julia ^a   Dähn, Karsten ^a   Morgenthaler, Nils ^a   Scherbaum, Werner A ^a,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Diabetes Specialty Practice   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; ONSET AGE; T LYMPHOCYTE;

EID: 0031002056     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.4.524     Document Type: Article

References (26)

1. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
2. Karjalainen, J, Salmela P, Ilonen J, Surgel H-M, Knip M: A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-886, 1989
3. Irvine WJ, Sawers JSA, Feek CM, Prescott RJ, Duncan LJP: The value of islet-cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in diabetes mellitus. J Clin Lab Immunol 2:23-26, 1979
4. Groop LC, Bottazzo GF, Doniach D: Islet-cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
5. Di Mario U, Irvine J, Borsey DQ, Kyner JL, Weston J, Galfo C: Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 25:392-395, 1983
6. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
7. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
8. Gottsäter A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G: Islet-cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients. Acta Diabetol 31:226-231, 1994
9. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341:927-928, 1993
10. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622-626, 1996
11. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1994
12. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet-cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
13. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA, the DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356, 1996
14. Verge, CF, Gianini R, Kawasaki E, Liping Y, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes m first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
15. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ: GAD antibodies in NIDDM: 10-year follow-up from the diagnosis. Diabetes Care 18:1557-1565, 1995
16. Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G: β-cell function in relation to islet-cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902-910, 1993
17. Gleichmann H, Zörcher B, Greulich B, Gries FR, Henrich HR, Bertrams J, Kolb H: Correlation of islet-cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27:90-92, 1984
18. Boehm BO, Scherbaum WA, Schöffling K, Kühnl P, Althoff P, Manfras B, Usadel K-H, Trucco M: Prevalence of HLA-DQ β chain non-Asp alleles in type I (insulin-dependent) diabetics with young and older ages of onset. Klin Wochenschr 69:687-689, 1991
19. Pitman, WB, Acton RT, Barger BO, Bell DS, Go RCP, Murphy CC, Roseman JM: HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age 40. Diabetes 31:122-125, 1982
20. Groop LC, Miettinen A, Groop, P-H, Meri S, Koskimies S, Bottazzo GF: Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37:99-103, 1988
21. Scherbaum WA, Mirakian R, Pujol-Borrell R, Dean BM, Bottazzo GF: Immunochemistry in the study and diagnosis of organ-specific autoimmune disease. In Immunochemistry: Modern Methods and Applications. Polak JM, Van Noorden S, Eds. Bristol, UK, Wright, 1986, p. 456-476
22. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M: Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607-1608, 1994
23. Lohmann T, Scherbaum WA: T-cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Horm Metab Res 28:357-360, 1996
24. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125-2129, 1994
25. Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck H-M, Christie MR, Scherbaum WA: Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiffman syndrome. Autoimmunity. In press
26. Pugliese A, Gianini R, Moromisato R, Awdeh ZL, Alper CA, Erlich HA, Jackson RA, Eisenbarth GS: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet-cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 44:608-613, 1995